Jack Eva M. 4
4 · Mersana Therapeutics, Inc. · Filed Sep 16, 2020
Insider Transaction Report
Form 4
Jack Eva M.
Chief Bus. Officer, Tres, Sec.
Transactions
- Exercise/Conversion
Common Stock
[F1]2020-09-14$1.53/sh+35,248$53,929→ 35,248 total - Sale
Common Stock
[F2]2020-09-14$22.00/sh−35,248$775,456→ 0 total - Exercise/Conversion
Stock Option (right to buy)
[F1][F3]2020-09-14−35,248→ 35,248 totalExercise: $1.53Exp: 2025-11-06→ Common Stock (35,248 underlying)
Footnotes (3)
- [F1]The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2020.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2020.
- [F3]The options vested in equal quarterly installments over the first four years after the vesting commencement date, June 12, 2015.
Signature
/s/ Eva Jack|2020-09-16